Observational studyCardiovascular diabetology2026
Rapid progression of coronary atherosclerosis across glycemic status: a serial coronary computed tomography angiography study from the PARADIGM registry.
Observational study in Cardiovascular diabetology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02803411 (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM)
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
Abstract
backgroundRapid progression of coronary atherosclerosis is associated with an increased risk of future adverse cardiovascular events. However, evidence regarding the association between glycemic status and rapid plaque progression (RPP) in the major epicardial coronary arteries remains limited.
methodsA total of 1296 subjects (mean age, 61 ± 9 years; 56.9% men) from the PARADIGM (Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography IMaging) registry who underwent serial coronary computed tomography angiography and had available glycemic data were included. The median inter-scan interval was 3.2 (interquartile range, 2.6-4.4) years. Participants were classified according to glycemic status as having normal glycemic status, prediabetes, or diabetes. Percent atheroma volume (PAV) was calculated as plaque volume divided by vessel volume and multiplied by 100. RPP was defined as an increase in PAV of ≥ 1.0%/year.
resultsAnnual changes in PAV (%/year) differed significantly across glycemic groups (normal glycemic status, 0.30 [0.00-0.98]; prediabetes, 0.35 [0.04-0.98]; diabetes, 0.65 [0.19-1.54]; overall P < 0.001). Similarly, the incidence of RPP differed significantly across glycemic groups (normal glycemic status, 25.6%; prediabetes, 25.2%; diabetes, 38.5%; overall P < 0.001). In multivariable logistic regression analyses adjusting for clinical risk factors and baseline plaque burden, diabetes was independently associated with higher odds of RPP compared with normal glycemic status, whereas prediabetes was not. Among participants without diabetes at baseline, RPP was more frequent in those who developed new-onset diabetes than in those who did not (36.1% vs. 24.2%; P = 0.039).
conclusionsDiabetes, but not prediabetes, was independently associated with rapid progression of coronary atherosclerosis. Furthermore, the higher incidence of RPP among participants who developed new-onset diabetes suggests that the development of diabetes may represent an important threshold for accelerated coronary plaque progression.
trial registrationClinicalTrials.gov (NCT02803411).
Indexed as
Identifiers
42850638What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.